Clinical Trial Update: High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updates show BRC-001, a cannabidiol plant extract, being studied to improve aromatase inhibitor-induced arthralgia in women with breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ
• Estrogen Receptor-positive Breast Cancer
• Progesterone Receptor-positive Breast Cancer

Drugs mentioned

• BRC-001 (cannabidiol)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Status: SUSPENDED